Literature DB >> 27080832

French pharmacovigilance: Missions, organization and perspectives.

Thierry Vial1.   

Abstract

Pharmacovigilance aims to identify unknown adverse drug reactions once clinical development is complete, in order to promote improved use of drugs, and thus a reduction in risk for every exposed patient. We describe in this article the missions of French pharmacovigilance system, including French drug agency, Regional Centers of Pharmacovigilance, health professionals, pharmaceutical companies, patients and their associations. We also develop the French pharmacovigilance organization, its perspectives and challenges, both in French and European levels.
Copyright © 2016. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Adverse drug reactions; Drug safety; Pharmacovigilance

Mesh:

Year:  2016        PMID: 27080832     DOI: 10.1016/j.therap.2016.02.029

Source DB:  PubMed          Journal:  Therapie        ISSN: 0040-5957            Impact factor:   2.070


  12 in total

1.  A comparative study of QT prolongation with serotonin reuptake inhibitors.

Authors:  Ana Ojero-Senard; Justine Benevent; Emmanuelle Bondon-Guitton; Geneviève Durrieu; Leila Chebane; Melanie Araujo; Francois Montastruc; Jean-Louis Montastruc
Journal:  Psychopharmacology (Berl)       Date:  2017-08-03       Impact factor: 4.530

2.  Drug-induced osteoporosis/osteomalacia: analysis in the French and Spanish pharmacovigilance databases.

Authors:  Quentin Dardonville; Esther Salguiero; Vanessa Rousseau; Leila Chebane; Jean Luc Faillie; Sophie Gautier; Jean Louis Montastruc; Alfonso Carvajal; Haleh Bagheri
Journal:  Eur J Clin Pharmacol       Date:  2019-08-29       Impact factor: 2.953

3.  Medication errors with tramadol drops in children.

Authors:  Florence Moulis; Geneviève Durrieu; Kamel Masmoudi; Marie Gervoise Boyer; Fanny Rocher; François Montastruc; Jean-Louis Montastruc
Journal:  Eur J Clin Pharmacol       Date:  2017-11-06       Impact factor: 2.953

4.  Serious adverse drug reactions with sacubitril/valsartan Entresto®: a French pharmacovigilance survey.

Authors:  Florence Moulis; Vanessa Rousseau; Leila Chebane; Amandine Gouverneur; Louise Gaboriau; Jean-Luc Faillie; Geneviève Durrieu; François Montastruc; Jean-Louis Montastruc
Journal:  Eur J Clin Pharmacol       Date:  2018-04-14       Impact factor: 2.953

5.  Concomitant medications and obstructive sleep apnoea.

Authors:  François Montastruc; Agnès Sommet; Jean-Louis Montastruc
Journal:  Br J Clin Pharmacol       Date:  2017-07-04       Impact factor: 4.335

6.  Adverse Drug Reactions Involving Protein Kinase Inhibitors: A French Pharmacovigilance Database Study Comparing Safety in Younger and Older Patients (≥ 75 years) with Cancer.

Authors:  Vincent Clapes; Vanessa Rousseau; Fabien Despas; Jean-Louis Montastruc; Pascale Olivier
Journal:  Pharmaceut Med       Date:  2019-02

7.  Breast cancer and spironolactone: an observational postmarketing study.

Authors:  Pierre Sabatier; Jacques Amar; François Montastruc; Vanessa Rousseau; Leila Chebane; Béatrice Bouhanick; Jean-Louis Montastruc
Journal:  Eur J Clin Pharmacol       Date:  2019-08-15       Impact factor: 2.953

8.  Informativeness of patient initial reports of adverse drug reactions. Can it be improved by a pharmacovigilance centre?

Authors:  F Kheloufi; A Default; F Rouby; D Laugier-Castellan; M Boyer; B Rodrigues; J Ponte-Astoul; M J Jean-Pastor; O Blin; J Micallef
Journal:  Eur J Clin Pharmacol       Date:  2017-04-08       Impact factor: 2.953

9.  Completeness of Spontaneous Adverse Drug Reaction Reports Sent by General Practitioners to a Regional Pharmacovigilance Centre: A Descriptive Study.

Authors:  Geneviève Durrieu; Julien Jacquot; Mathilde Mège; Emmanuelle Bondon-Guitton; Vanessa Rousseau; François Montastruc; Jean-Louis Montastruc
Journal:  Drug Saf       Date:  2016-12       Impact factor: 5.606

10.  Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance database.

Authors:  Quentin Scanvion; Johana Béné; Sophie Gautier; Aurélie Grandvuillemin; Christine Le Beller; Chouki Chenaf; Nicolas Etienne; Solenn Brousseau; Alexis B Cortot; Laurent Mortier; Delphine Staumont-Sallé; Franck Morschhauser; Alexandra Forestier; Matthieu Groh; David Launay; Eric Hachulla; Myriam Labalette; Jean-Emmanuel Kahn; Guillaume Lefèvre
Journal:  Oncoimmunology       Date:  2020-04-07       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.